Prodia Widyahusada Tbk PT (PRDA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Prodia Widyahusada Tbk PT (PRDA) has a cash flow conversion efficiency ratio of 0.073x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp169.15 Billion ≈ $9.91 Million USD) by net assets (Rp2.31 Trillion ≈ $135.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Prodia Widyahusada Tbk PT market cap and net worth for the company's overall valuation and market capitalisation.
Prodia Widyahusada Tbk PT - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Prodia Widyahusada Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Prodia Widyahusada Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Prodia Widyahusada Tbk PT ranked by their cash flow conversion efficiency. Explore earnings quality score of Prodia Widyahusada Tbk PT to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vieworks Co. Ltd
KQ:100120
|
0.043x |
|
Manulife Holdings Bhd
KLSE:1058
|
-0.011x |
|
Goodbaby International Holdings Limited
F:GBH
|
0.041x |
|
DIRECTA SIM SPA
F:ZP7
|
N/A |
|
Digia Oyj
HE:DIGIA
|
0.083x |
|
Portman Ridge Finance Corp
NASDAQ:PTMN
|
-0.003x |
|
Inission AB (publ)
ST:INISS-B
|
0.058x |
|
Wasko S.A.
WAR:WAS
|
0.045x |
Annual Cash Flow Conversion Efficiency for Prodia Widyahusada Tbk PT (2013–2024)
The table below shows the annual cash flow conversion efficiency of Prodia Widyahusada Tbk PT from 2013 to 2024. View Prodia Widyahusada Tbk PT share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp2.48 Trillion ≈ $145.59 Million |
Rp476.64 Billion ≈ $27.93 Million |
0.192x | +10.10% |
| 2023-12-31 | Rp2.36 Trillion ≈ $138.32 Million |
Rp411.29 Billion ≈ $24.10 Million |
0.174x | -18.94% |
| 2022-12-31 | Rp2.31 Trillion ≈ $135.42 Million |
Rp496.73 Billion ≈ $29.11 Million |
0.215x | -37.72% |
| 2021-12-31 | Rp2.25 Trillion ≈ $131.98 Million |
Rp777.27 Billion ≈ $45.54 Million |
0.345x | +41.99% |
| 2020-12-31 | Rp1.79 Trillion ≈ $104.79 Million |
Rp434.63 Billion ≈ $25.47 Million |
0.243x | +18.00% |
| 2019-12-31 | Rp1.66 Trillion ≈ $97.25 Million |
Rp341.82 Billion ≈ $20.03 Million |
0.206x | +34.16% |
| 2018-12-31 | Rp1.56 Trillion ≈ $91.54 Million |
Rp239.83 Billion ≈ $14.05 Million |
0.154x | +123.89% |
| 2017-12-31 | Rp1.36 Trillion ≈ $79.87 Million |
Rp93.47 Billion ≈ $5.48 Million |
0.069x | -27.13% |
| 2016-12-31 | Rp1.27 Trillion ≈ $74.26 Million |
Rp119.25 Billion ≈ $6.99 Million |
0.094x | -92.36% |
| 2015-12-31 | Rp126.33 Billion ≈ $7.40 Million |
Rp155.61 Billion ≈ $9.12 Million |
1.232x | +56.52% |
| 2014-12-31 | Rp134.25 Billion ≈ $7.87 Million |
Rp105.66 Billion ≈ $6.19 Million |
0.787x | -15.91% |
| 2013-12-31 | Rp88.32 Billion ≈ $5.18 Million |
Rp82.66 Billion ≈ $4.84 Million |
0.936x | -- |
About Prodia Widyahusada Tbk PT
PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia specialty clinics; and offers vaccination, doctor consultation, and home services. It serves to individuals, doctors, and corporate and partnerships. The company was founded in 1973 and is headquartered in … Read more